Female Reproductive System Neoplasm — Trials

Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 351–400 of 649 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05479045	A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients	not yet recruiting	Phase 2	24	Georgetown UniversityOTHER	1	Mar 16, 2026	clinicaltrials
NCT07472140	PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer	recruiting	Phase 2 / Phase 3	120	N.N. Alexandrov National Cancer CentreOTHER_GOV	1